116726767234The purpose of the present invention is to provide a novel compound having ACC2 inhibition activity and to provide a pharmaceutical composition containing the compound. Provided are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In formula (I) R represents a substituted or unsubstituted fused aromatic heterocyclic group represented by formula (II) (in formula (II) ring B represents a 5 membered ring and ring C represents a 6 membered ring) ring A represents a substituted or unsubstituted nonaromatic carbocyclic ring or the like L represents O (CRR)m or the like L represents O (CRR)n or the like each R independently represents hydrogen or the like each R independently represents hydrogen or the like each m independently represents an integer of 0 1 2 or 3 each n independently represents an integer of 1 2 or 3 R represents a substituted or unsubstituted alkyl R represents hydrogen or a substituted or unsubstituted alkyl and R represents a substituted or unsubstituted alkyl carbonyl or the like).
